Sabra Healthcare REIT Inc’s filing revealed that its Director Cusack Catherine acquired Company’s shares for reported $0.1 million on May 22 ’24. In the deal valued at $14.43 per share,7,000 shares were bought. As a result of this transaction, Cusack Catherine now holds 46,385 shares worth roughly $0.78 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, FOSTER MICHAEL J sold 10,000 shares, generating $146,830 in total proceeds. Upon selling the shares at $14.68, the Director now owns 63,923 shares.
Before that, Costa Michael Lourenco bought 1,947 shares. Sabra Healthcare REIT Inc shares valued at $24,591 were divested by the Executive VP, CFO & Secretary at a price of $12.63 per share. As a result of the transaction, Costa Michael Lourenco now holds 183,218 shares, worth roughly $3.07 million.
Deutsche Bank initiated its Sabra Healthcare REIT Inc [SBRA] rating to a Buy in a research note published on January 30, 2024; the price target was $21. A number of analysts have revised their coverage, including BMO Capital Markets’s analysts, who decreased its forecast for the stock in mid October from “an Outperform” to “a Market perform”. Wells Fargo also remained covering SBRA and has increased its forecast on October 16, 2023 with a “an Equal weight” recommendation from previously “an Underweight” rating. BofA Securities revised its rating on October 10, 2023. It rated SBRA as “a Buy” which previously was an “a Neutral”.
Price Performance Review of SBRA
On Tuesday, Sabra Healthcare REIT Inc [NASDAQ:SBRA] saw its stock jump 1.51% to $16.78. Over the last five days, the stock has gained 2.94%. Sabra Healthcare REIT Inc shares have risen nearly 17.59% since the year began. Nevertheless, the stocks have risen 40.51% over the past one year. While a 52-week high of $16.94 was reached on 08/08/24, a 52-week low of $11.99 was recorded on 02/05/24. SMA at 50 days reached $15.93, while 200 days put it at $14.55.
Levels Of Support And Resistance For SBRA Stock
The 24-hour chart illustrates a support level at 16.48, which if violated will result in even more drops to 16.18. On the upside, there is a resistance level at 16.94. A further resistance level may holdings at 17.09. The Relative Strength Index (RSI) on the 14-day chart is 60.02, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.27, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 14.68%. Stochastics%K at 73.09% indicates the stock is a holding.
How much short interest is there in Sabra Healthcare REIT Inc?
A steep rise in short interest was recorded in Sabra Healthcare REIT Inc stocks on 2024-07-31, dropping by -0.61 million shares to a total of 13.24 million shares. Yahoo Finance data shows the prior-month short interest on 2024-06-28 was 13.85 million shares. There was a decline of -4.58%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on October 03, 2023 when Wedbush began covering the stock and recommended ‘”an Outperform”‘ rating along with a $16 price target.
